1. Home
  2. ACTU vs WNEB Comparison

ACTU vs WNEB Comparison

Compare ACTU & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • WNEB
  • Stock Information
  • Founded
  • ACTU 2015
  • WNEB 1853
  • Country
  • ACTU United States
  • WNEB United States
  • Employees
  • ACTU N/A
  • WNEB 348
  • Industry
  • ACTU
  • WNEB Savings Institutions
  • Sector
  • ACTU
  • WNEB Finance
  • Exchange
  • ACTU NYSE
  • WNEB Nasdaq
  • Market Cap
  • ACTU 153.1M
  • WNEB 185.6M
  • IPO Year
  • ACTU 2024
  • WNEB N/A
  • Fundamental
  • Price
  • ACTU $8.73
  • WNEB $8.83
  • Analyst Decision
  • ACTU
  • WNEB Hold
  • Analyst Count
  • ACTU 0
  • WNEB 3
  • Target Price
  • ACTU N/A
  • WNEB $8.50
  • AVG Volume (30 Days)
  • ACTU 49.9K
  • WNEB 28.5K
  • Earning Date
  • ACTU 11-21-2024
  • WNEB 10-23-2024
  • Dividend Yield
  • ACTU N/A
  • WNEB 3.18%
  • EPS Growth
  • ACTU N/A
  • WNEB N/A
  • EPS
  • ACTU N/A
  • WNEB 0.52
  • Revenue
  • ACTU N/A
  • WNEB $72,500,000.00
  • Revenue This Year
  • ACTU N/A
  • WNEB N/A
  • Revenue Next Year
  • ACTU N/A
  • WNEB $6.24
  • P/E Ratio
  • ACTU N/A
  • WNEB $17.03
  • Revenue Growth
  • ACTU N/A
  • WNEB N/A
  • 52 Week Low
  • ACTU $5.51
  • WNEB $6.00
  • 52 Week High
  • ACTU $10.16
  • WNEB $9.25
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • WNEB 55.85
  • Support Level
  • ACTU N/A
  • WNEB $8.72
  • Resistance Level
  • ACTU N/A
  • WNEB $8.95
  • Average True Range (ATR)
  • ACTU 0.00
  • WNEB 0.16
  • MACD
  • ACTU 0.00
  • WNEB 0.00
  • Stochastic Oscillator
  • ACTU 0.00
  • WNEB 62.96

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the Company's revenues, profits, and assets are derived by the Bank from banking products and services.

Share on Social Networks: